ANNIKE DON-LEVY: Open Payments
NPI 1093226300 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 13 payments from 7 companies in 2025. Trend: 2023 $390 · 2024 $301 · 2025 $347
Food & beverage: $347
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $155 |
| Daiichi Sankyo Inc. | 2 | $59 |
| Boston Scientific Corporation | 1 | $35 |
| SANOFI-AVENTIS U.S. LLC | 1 | $34 |
| COLOPLAST CORP | 1 | $24 |
| UROGEN PHARMA, INC. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: GEMTESA, AMS 800 Artificial Urinary Sphincter, REZUROCK, DATROWAY, Enhertu, SpeediCath, KEYTRUDA.
Industry payments across FL — which companies pay providers there.
